Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Alto Neuroscience Promotes Nick Smith To President and Chief Financial Officer

PUBLIC · ANROAug 27, 2026about 3 hours ago

Position

Chief Financial Officer

Company

Alto Neuroscience

Nick Smith
Mountain ViewBiotechnologyHealth Care

Description

Alto Neuroscience has announced the promotion of Nick Smith to president and chief financial officer. The promotion is effective August 26, 2026.

Company Information

Company

Alto Neuroscience

Location

Mountain View, California, United States

About

Alto Neuroscience is a biopharmaceutical company redefining psychiatry through its Precision Psychiatry Platform™, which leverages individuals’ neurobiology to develop personalized and highly effective medicines that help patients get better faster. By integrating biomarkers such as EEG and wearable data, behavioral patterns, genetics, and other biological factors, Alto uses AI-driven insights to match each patient with the treatment they are most likely to respond to—bringing a new era of precision and effectiveness to mental health care.

Don't miss Alto Neuroscience's next move

Get an email the moment Alto Neuroscience changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Patricio
Senior decision-maker at this company
••••••••@••••••••

See Patricio's verified email →

Faizan
Senior decision-maker at this company
••••••••@••••••••

See Faizan's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Alto Neuroscience's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Alto Neuroscience changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.